Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations

Abstract Objective Congenital generalized lipodystrophy (CGL) is an autosomal recessive disorder characterized by marked scarcity of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early-onset diabetes. Mutation of the BSCL2 / SEIPIN gene causes the most sever...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolism, clinical and experimental clinical and experimental, 2016-04, Vol.65 (4), p.543-556
Hauptverfasser: Mori, Eisaku, Fujikura, Junji, Noguchi, Michio, Nakao, Kazuhiro, Matsubara, Masaki, Sone, Masakatsu, Taura, Daisuke, Kusakabe, Toru, Ebihara, Ken, Tanaka, Takayuki, Hosoda, Kiminori, Takahashi, Kazutoshi, Asaka, Isao, Inagaki, Nobuya, Nakao, Kazuwa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 556
container_issue 4
container_start_page 543
container_title Metabolism, clinical and experimental
container_volume 65
creator Mori, Eisaku
Fujikura, Junji
Noguchi, Michio
Nakao, Kazuhiro
Matsubara, Masaki
Sone, Masakatsu
Taura, Daisuke
Kusakabe, Toru
Ebihara, Ken
Tanaka, Takayuki
Hosoda, Kiminori
Takahashi, Kazutoshi
Asaka, Isao
Inagaki, Nobuya
Nakao, Kazuwa
description Abstract Objective Congenital generalized lipodystrophy (CGL) is an autosomal recessive disorder characterized by marked scarcity of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early-onset diabetes. Mutation of the BSCL2 / SEIPIN gene causes the most severe form of CGL. The aim of this study was to generate induced pluripotent stem (iPS) cells from patients with CGL harboring BSCL2 / SEIPIN mutations. Methods Skin biopsies were obtained from two Japanese patients with CGL harboring different nonsense mutations (E189X and R275X) in BSCL2 / SEIPIN . The fibroblasts thus obtained were infected with retroviruses encoding OCT4, SOX2, c-MYC, and KLF4. The generated iPS cells were evaluated for pluripotency by examining the expression of pluripotency markers (alkaline phosphatase, SSEA-4, TRA-1-60, and NANOG) and their ability to differentiate to three germ layers in vitro by forming embryoid bodies, and to form teratomas in vivo. Adipogenic capacity of differentiated BSCL2-iPS cells was determined by oil red O and adipose differentiation-related protein (ADRP) staining. Rescue experiments were also performed using stable expression of wild-type BSCL2. A coimmunoprecipitation assay was conducted to investigate the interaction of SEIPIN with ADRP. Results iPS cells were generated from fibroblasts of the two patients with CGL. Each of the patient-derived iPS (BSCL2-iPS) clones showed all of the hallmarks of pluripotency and could differentiate into derivatives of all three germ layers in vitro by forming embryoid bodies, and form teratomas after injection into mouse testes. BSCL2-iPS cells maintained the mutations in BSCL2 and lacked intact BSCL2. Upon adipogenic differentiation, BSCL2-iPS cells exhibited marked reduction of lipid droplet formation concomitant with diffuse cytoplasmic distribution of ADRP, compared with iPS cells from healthy individuals. Forced expression of BSCL2 not only rescued the lipid accumulation defects, but also restored cytoplasmic punctate localization of ADRP in BSCL2-iPS cells. Coimmunoprecipitation indicated SEIPIN interacted with ADRP. Conclusion BSCL2-iPS cells that recapitulate the lipodystrophic phenotypes in vitro could provide valuable models with which to study the physiology of lipid accumulation and the pathology of human lipodystrophy. We found that BSCL2 defines the localization of ADRP, which has a role in lipid accumulation and adipogenic differentiation.
doi_str_mv 10.1016/j.metabol.2015.12.015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1805495810</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0026049516000032</els_id><sourcerecordid>1805495810</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-162aebf3d7d0c9b8a01e4e153653960f9c411f015e468ab85105a3d8f187a3483</originalsourceid><addsrcrecordid>eNqFksGO1DAMhiMEYoeFRwDlyKXFaZs0vYBgBLsrjcRh4RylacpmaJuQpKB5e1zNwIELUiRL8f_b8ecQ8pJByYCJN8dytln3fiorYLxkVYnhEdkxXleFFACPyQ6gEgU0Hb8iz1I6AkDbSvGUXFWiazlvxI6EuzloF-1A9eCC_2YXZ6jRQRuXT9QteIbVYDpMa0RBtkumKduZGjtNiY7Rz3TCxHBKOfrwgPags0NZor9cfqAf7veHis5rxlu_pOfkyainZF9c4jX5-unjl_1tcfh8c7d_fyhMw-tcMFFp24_10A5gul5qYLaxOJzgdSdg7EzD2Igj20ZI3UvOgOt6kCOTra4bWV-T1-e6Ifofq01ZzS5tb9aL9WtSTAJHMpIBSvlZaqJPKdpRhehmHU-Kgdpgq6O6wFYbbMUqhQF9ry4t1n62w1_XH7ooeHcWWBz0p7NRJYNkECcSN1kN3v23xdt_KpjJ4Yr09N2ebDr6NS5IUTGV0KDut41vC2f4AQDqqv4Nx1OpFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1805495810</pqid></control><display><type>article</type><title>Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Mori, Eisaku ; Fujikura, Junji ; Noguchi, Michio ; Nakao, Kazuhiro ; Matsubara, Masaki ; Sone, Masakatsu ; Taura, Daisuke ; Kusakabe, Toru ; Ebihara, Ken ; Tanaka, Takayuki ; Hosoda, Kiminori ; Takahashi, Kazutoshi ; Asaka, Isao ; Inagaki, Nobuya ; Nakao, Kazuwa</creator><creatorcontrib>Mori, Eisaku ; Fujikura, Junji ; Noguchi, Michio ; Nakao, Kazuhiro ; Matsubara, Masaki ; Sone, Masakatsu ; Taura, Daisuke ; Kusakabe, Toru ; Ebihara, Ken ; Tanaka, Takayuki ; Hosoda, Kiminori ; Takahashi, Kazutoshi ; Asaka, Isao ; Inagaki, Nobuya ; Nakao, Kazuwa</creatorcontrib><description>Abstract Objective Congenital generalized lipodystrophy (CGL) is an autosomal recessive disorder characterized by marked scarcity of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early-onset diabetes. Mutation of the BSCL2 / SEIPIN gene causes the most severe form of CGL. The aim of this study was to generate induced pluripotent stem (iPS) cells from patients with CGL harboring BSCL2 / SEIPIN mutations. Methods Skin biopsies were obtained from two Japanese patients with CGL harboring different nonsense mutations (E189X and R275X) in BSCL2 / SEIPIN . The fibroblasts thus obtained were infected with retroviruses encoding OCT4, SOX2, c-MYC, and KLF4. The generated iPS cells were evaluated for pluripotency by examining the expression of pluripotency markers (alkaline phosphatase, SSEA-4, TRA-1-60, and NANOG) and their ability to differentiate to three germ layers in vitro by forming embryoid bodies, and to form teratomas in vivo. Adipogenic capacity of differentiated BSCL2-iPS cells was determined by oil red O and adipose differentiation-related protein (ADRP) staining. Rescue experiments were also performed using stable expression of wild-type BSCL2. A coimmunoprecipitation assay was conducted to investigate the interaction of SEIPIN with ADRP. Results iPS cells were generated from fibroblasts of the two patients with CGL. Each of the patient-derived iPS (BSCL2-iPS) clones showed all of the hallmarks of pluripotency and could differentiate into derivatives of all three germ layers in vitro by forming embryoid bodies, and form teratomas after injection into mouse testes. BSCL2-iPS cells maintained the mutations in BSCL2 and lacked intact BSCL2. Upon adipogenic differentiation, BSCL2-iPS cells exhibited marked reduction of lipid droplet formation concomitant with diffuse cytoplasmic distribution of ADRP, compared with iPS cells from healthy individuals. Forced expression of BSCL2 not only rescued the lipid accumulation defects, but also restored cytoplasmic punctate localization of ADRP in BSCL2-iPS cells. Coimmunoprecipitation indicated SEIPIN interacted with ADRP. Conclusion BSCL2-iPS cells that recapitulate the lipodystrophic phenotypes in vitro could provide valuable models with which to study the physiology of lipid accumulation and the pathology of human lipodystrophy. We found that BSCL2 defines the localization of ADRP, which has a role in lipid accumulation and adipogenic differentiation.</description><identifier>ISSN: 0026-0495</identifier><identifier>EISSN: 1532-8600</identifier><identifier>DOI: 10.1016/j.metabol.2015.12.015</identifier><identifier>PMID: 26975546</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adipocyte ; Adipogenesis - genetics ; Biopsy ; BSCL2/SEIPIN induced pluripotent stem cell ; Cell Differentiation - genetics ; Codon, Nonsense - genetics ; Congenital generalized lipodystrophy ; Embryoid Bodies ; Endocrinology &amp; Metabolism ; Fibroblasts - metabolism ; GTP-Binding Protein gamma Subunits - genetics ; Humans ; Induced Pluripotent Stem Cells - metabolism ; Lipodystrophy, Congenital Generalized - genetics ; Lipodystrophy, Congenital Generalized - metabolism ; Membrane Proteins - metabolism ; Mutation - genetics ; Perilipin-2 ; Retrovirus ; Skin - metabolism ; Teratoma - genetics</subject><ispartof>Metabolism, clinical and experimental, 2016-04, Vol.65 (4), p.543-556</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-162aebf3d7d0c9b8a01e4e153653960f9c411f015e468ab85105a3d8f187a3483</citedby><cites>FETCH-LOGICAL-c453t-162aebf3d7d0c9b8a01e4e153653960f9c411f015e468ab85105a3d8f187a3483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.metabol.2015.12.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26975546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mori, Eisaku</creatorcontrib><creatorcontrib>Fujikura, Junji</creatorcontrib><creatorcontrib>Noguchi, Michio</creatorcontrib><creatorcontrib>Nakao, Kazuhiro</creatorcontrib><creatorcontrib>Matsubara, Masaki</creatorcontrib><creatorcontrib>Sone, Masakatsu</creatorcontrib><creatorcontrib>Taura, Daisuke</creatorcontrib><creatorcontrib>Kusakabe, Toru</creatorcontrib><creatorcontrib>Ebihara, Ken</creatorcontrib><creatorcontrib>Tanaka, Takayuki</creatorcontrib><creatorcontrib>Hosoda, Kiminori</creatorcontrib><creatorcontrib>Takahashi, Kazutoshi</creatorcontrib><creatorcontrib>Asaka, Isao</creatorcontrib><creatorcontrib>Inagaki, Nobuya</creatorcontrib><creatorcontrib>Nakao, Kazuwa</creatorcontrib><title>Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations</title><title>Metabolism, clinical and experimental</title><addtitle>Metabolism</addtitle><description>Abstract Objective Congenital generalized lipodystrophy (CGL) is an autosomal recessive disorder characterized by marked scarcity of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early-onset diabetes. Mutation of the BSCL2 / SEIPIN gene causes the most severe form of CGL. The aim of this study was to generate induced pluripotent stem (iPS) cells from patients with CGL harboring BSCL2 / SEIPIN mutations. Methods Skin biopsies were obtained from two Japanese patients with CGL harboring different nonsense mutations (E189X and R275X) in BSCL2 / SEIPIN . The fibroblasts thus obtained were infected with retroviruses encoding OCT4, SOX2, c-MYC, and KLF4. The generated iPS cells were evaluated for pluripotency by examining the expression of pluripotency markers (alkaline phosphatase, SSEA-4, TRA-1-60, and NANOG) and their ability to differentiate to three germ layers in vitro by forming embryoid bodies, and to form teratomas in vivo. Adipogenic capacity of differentiated BSCL2-iPS cells was determined by oil red O and adipose differentiation-related protein (ADRP) staining. Rescue experiments were also performed using stable expression of wild-type BSCL2. A coimmunoprecipitation assay was conducted to investigate the interaction of SEIPIN with ADRP. Results iPS cells were generated from fibroblasts of the two patients with CGL. Each of the patient-derived iPS (BSCL2-iPS) clones showed all of the hallmarks of pluripotency and could differentiate into derivatives of all three germ layers in vitro by forming embryoid bodies, and form teratomas after injection into mouse testes. BSCL2-iPS cells maintained the mutations in BSCL2 and lacked intact BSCL2. Upon adipogenic differentiation, BSCL2-iPS cells exhibited marked reduction of lipid droplet formation concomitant with diffuse cytoplasmic distribution of ADRP, compared with iPS cells from healthy individuals. Forced expression of BSCL2 not only rescued the lipid accumulation defects, but also restored cytoplasmic punctate localization of ADRP in BSCL2-iPS cells. Coimmunoprecipitation indicated SEIPIN interacted with ADRP. Conclusion BSCL2-iPS cells that recapitulate the lipodystrophic phenotypes in vitro could provide valuable models with which to study the physiology of lipid accumulation and the pathology of human lipodystrophy. We found that BSCL2 defines the localization of ADRP, which has a role in lipid accumulation and adipogenic differentiation.</description><subject>Adipocyte</subject><subject>Adipogenesis - genetics</subject><subject>Biopsy</subject><subject>BSCL2/SEIPIN induced pluripotent stem cell</subject><subject>Cell Differentiation - genetics</subject><subject>Codon, Nonsense - genetics</subject><subject>Congenital generalized lipodystrophy</subject><subject>Embryoid Bodies</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Fibroblasts - metabolism</subject><subject>GTP-Binding Protein gamma Subunits - genetics</subject><subject>Humans</subject><subject>Induced Pluripotent Stem Cells - metabolism</subject><subject>Lipodystrophy, Congenital Generalized - genetics</subject><subject>Lipodystrophy, Congenital Generalized - metabolism</subject><subject>Membrane Proteins - metabolism</subject><subject>Mutation - genetics</subject><subject>Perilipin-2</subject><subject>Retrovirus</subject><subject>Skin - metabolism</subject><subject>Teratoma - genetics</subject><issn>0026-0495</issn><issn>1532-8600</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFksGO1DAMhiMEYoeFRwDlyKXFaZs0vYBgBLsrjcRh4RylacpmaJuQpKB5e1zNwIELUiRL8f_b8ecQ8pJByYCJN8dytln3fiorYLxkVYnhEdkxXleFFACPyQ6gEgU0Hb8iz1I6AkDbSvGUXFWiazlvxI6EuzloF-1A9eCC_2YXZ6jRQRuXT9QteIbVYDpMa0RBtkumKduZGjtNiY7Rz3TCxHBKOfrwgPags0NZor9cfqAf7veHis5rxlu_pOfkyainZF9c4jX5-unjl_1tcfh8c7d_fyhMw-tcMFFp24_10A5gul5qYLaxOJzgdSdg7EzD2Igj20ZI3UvOgOt6kCOTra4bWV-T1-e6Ifofq01ZzS5tb9aL9WtSTAJHMpIBSvlZaqJPKdpRhehmHU-Kgdpgq6O6wFYbbMUqhQF9ry4t1n62w1_XH7ooeHcWWBz0p7NRJYNkECcSN1kN3v23xdt_KpjJ4Yr09N2ebDr6NS5IUTGV0KDut41vC2f4AQDqqv4Nx1OpFA</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Mori, Eisaku</creator><creator>Fujikura, Junji</creator><creator>Noguchi, Michio</creator><creator>Nakao, Kazuhiro</creator><creator>Matsubara, Masaki</creator><creator>Sone, Masakatsu</creator><creator>Taura, Daisuke</creator><creator>Kusakabe, Toru</creator><creator>Ebihara, Ken</creator><creator>Tanaka, Takayuki</creator><creator>Hosoda, Kiminori</creator><creator>Takahashi, Kazutoshi</creator><creator>Asaka, Isao</creator><creator>Inagaki, Nobuya</creator><creator>Nakao, Kazuwa</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20160401</creationdate><title>Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations</title><author>Mori, Eisaku ; Fujikura, Junji ; Noguchi, Michio ; Nakao, Kazuhiro ; Matsubara, Masaki ; Sone, Masakatsu ; Taura, Daisuke ; Kusakabe, Toru ; Ebihara, Ken ; Tanaka, Takayuki ; Hosoda, Kiminori ; Takahashi, Kazutoshi ; Asaka, Isao ; Inagaki, Nobuya ; Nakao, Kazuwa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-162aebf3d7d0c9b8a01e4e153653960f9c411f015e468ab85105a3d8f187a3483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adipocyte</topic><topic>Adipogenesis - genetics</topic><topic>Biopsy</topic><topic>BSCL2/SEIPIN induced pluripotent stem cell</topic><topic>Cell Differentiation - genetics</topic><topic>Codon, Nonsense - genetics</topic><topic>Congenital generalized lipodystrophy</topic><topic>Embryoid Bodies</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Fibroblasts - metabolism</topic><topic>GTP-Binding Protein gamma Subunits - genetics</topic><topic>Humans</topic><topic>Induced Pluripotent Stem Cells - metabolism</topic><topic>Lipodystrophy, Congenital Generalized - genetics</topic><topic>Lipodystrophy, Congenital Generalized - metabolism</topic><topic>Membrane Proteins - metabolism</topic><topic>Mutation - genetics</topic><topic>Perilipin-2</topic><topic>Retrovirus</topic><topic>Skin - metabolism</topic><topic>Teratoma - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mori, Eisaku</creatorcontrib><creatorcontrib>Fujikura, Junji</creatorcontrib><creatorcontrib>Noguchi, Michio</creatorcontrib><creatorcontrib>Nakao, Kazuhiro</creatorcontrib><creatorcontrib>Matsubara, Masaki</creatorcontrib><creatorcontrib>Sone, Masakatsu</creatorcontrib><creatorcontrib>Taura, Daisuke</creatorcontrib><creatorcontrib>Kusakabe, Toru</creatorcontrib><creatorcontrib>Ebihara, Ken</creatorcontrib><creatorcontrib>Tanaka, Takayuki</creatorcontrib><creatorcontrib>Hosoda, Kiminori</creatorcontrib><creatorcontrib>Takahashi, Kazutoshi</creatorcontrib><creatorcontrib>Asaka, Isao</creatorcontrib><creatorcontrib>Inagaki, Nobuya</creatorcontrib><creatorcontrib>Nakao, Kazuwa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Metabolism, clinical and experimental</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mori, Eisaku</au><au>Fujikura, Junji</au><au>Noguchi, Michio</au><au>Nakao, Kazuhiro</au><au>Matsubara, Masaki</au><au>Sone, Masakatsu</au><au>Taura, Daisuke</au><au>Kusakabe, Toru</au><au>Ebihara, Ken</au><au>Tanaka, Takayuki</au><au>Hosoda, Kiminori</au><au>Takahashi, Kazutoshi</au><au>Asaka, Isao</au><au>Inagaki, Nobuya</au><au>Nakao, Kazuwa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations</atitle><jtitle>Metabolism, clinical and experimental</jtitle><addtitle>Metabolism</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>65</volume><issue>4</issue><spage>543</spage><epage>556</epage><pages>543-556</pages><issn>0026-0495</issn><eissn>1532-8600</eissn><abstract>Abstract Objective Congenital generalized lipodystrophy (CGL) is an autosomal recessive disorder characterized by marked scarcity of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early-onset diabetes. Mutation of the BSCL2 / SEIPIN gene causes the most severe form of CGL. The aim of this study was to generate induced pluripotent stem (iPS) cells from patients with CGL harboring BSCL2 / SEIPIN mutations. Methods Skin biopsies were obtained from two Japanese patients with CGL harboring different nonsense mutations (E189X and R275X) in BSCL2 / SEIPIN . The fibroblasts thus obtained were infected with retroviruses encoding OCT4, SOX2, c-MYC, and KLF4. The generated iPS cells were evaluated for pluripotency by examining the expression of pluripotency markers (alkaline phosphatase, SSEA-4, TRA-1-60, and NANOG) and their ability to differentiate to three germ layers in vitro by forming embryoid bodies, and to form teratomas in vivo. Adipogenic capacity of differentiated BSCL2-iPS cells was determined by oil red O and adipose differentiation-related protein (ADRP) staining. Rescue experiments were also performed using stable expression of wild-type BSCL2. A coimmunoprecipitation assay was conducted to investigate the interaction of SEIPIN with ADRP. Results iPS cells were generated from fibroblasts of the two patients with CGL. Each of the patient-derived iPS (BSCL2-iPS) clones showed all of the hallmarks of pluripotency and could differentiate into derivatives of all three germ layers in vitro by forming embryoid bodies, and form teratomas after injection into mouse testes. BSCL2-iPS cells maintained the mutations in BSCL2 and lacked intact BSCL2. Upon adipogenic differentiation, BSCL2-iPS cells exhibited marked reduction of lipid droplet formation concomitant with diffuse cytoplasmic distribution of ADRP, compared with iPS cells from healthy individuals. Forced expression of BSCL2 not only rescued the lipid accumulation defects, but also restored cytoplasmic punctate localization of ADRP in BSCL2-iPS cells. Coimmunoprecipitation indicated SEIPIN interacted with ADRP. Conclusion BSCL2-iPS cells that recapitulate the lipodystrophic phenotypes in vitro could provide valuable models with which to study the physiology of lipid accumulation and the pathology of human lipodystrophy. We found that BSCL2 defines the localization of ADRP, which has a role in lipid accumulation and adipogenic differentiation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26975546</pmid><doi>10.1016/j.metabol.2015.12.015</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-0495
ispartof Metabolism, clinical and experimental, 2016-04, Vol.65 (4), p.543-556
issn 0026-0495
1532-8600
language eng
recordid cdi_proquest_miscellaneous_1805495810
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adipocyte
Adipogenesis - genetics
Biopsy
BSCL2/SEIPIN induced pluripotent stem cell
Cell Differentiation - genetics
Codon, Nonsense - genetics
Congenital generalized lipodystrophy
Embryoid Bodies
Endocrinology & Metabolism
Fibroblasts - metabolism
GTP-Binding Protein gamma Subunits - genetics
Humans
Induced Pluripotent Stem Cells - metabolism
Lipodystrophy, Congenital Generalized - genetics
Lipodystrophy, Congenital Generalized - metabolism
Membrane Proteins - metabolism
Mutation - genetics
Perilipin-2
Retrovirus
Skin - metabolism
Teratoma - genetics
title Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A58%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impaired%20adipogenic%20capacity%20in%20induced%20pluripotent%20stem%20cells%20from%20lipodystrophic%20patients%20with%20BSCL2%20mutations&rft.jtitle=Metabolism,%20clinical%20and%20experimental&rft.au=Mori,%20Eisaku&rft.date=2016-04-01&rft.volume=65&rft.issue=4&rft.spage=543&rft.epage=556&rft.pages=543-556&rft.issn=0026-0495&rft.eissn=1532-8600&rft_id=info:doi/10.1016/j.metabol.2015.12.015&rft_dat=%3Cproquest_cross%3E1805495810%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1805495810&rft_id=info:pmid/26975546&rft_els_id=1_s2_0_S0026049516000032&rfr_iscdi=true